MedPath
HSA Approval

TALZENNA CAPSULE 0.1MG

SIN17238P

TALZENNA CAPSULE 0.1MG

TALZENNA CAPSULE 0.1MG

May 21, 2025

PFIZER PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPFIZER PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

L01XK04

Manufacturer Information

PFIZER PRIVATE LIMITED

Excella GmbH & Co. KG

Active Ingredients

Talazoparib tosylate eqv Talazoparib

0.1 mg

Talazoparib

Documents

Package Inserts

Talzenna Capsule PI.pdf

Approved: May 21, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.